Standigm Is An Ai Driven Drug Discovery Company Based In Seoulsouth Koreafounded In 2015The Company Has Raised A Total Of $78 25 Million In Funding From Various Investorsincluding Pavilion Capital And Sk Chemicalsstandigm Focuses On Enhancing Early Stage Drug Discovery Through Its Proprietary Ai Platformswhich Include The Symphony Platform For Target Identificationlead Generationand Drug Pipeline Development The Company Offers Ai Tools For Workflow Automation To Minimize False Starts In Drug Discovery And Efficiently Generate First In Class Compoundsstandigm Has A Strong Emphasis On Integrating Ai Throughout The Drug Discovery Processutilizing Models For Target Identificationlead Optimizationand Synthetic Researchwith A Portfolio Of 10 Filed Patentsstandigm Targets Areas Such As Extrapyramidal Disordersinflammatory Diseasesand Neurological Disordersthe Company Collaborates With Pharmaceutical Firms And Research Institutions To Advance Its Innovative Solutions
Arab Health
United Arab Emirates
27 Jan 2025
22
P.H
| Company Name | Standigm Inc |
| Country |
South Korea
|
| Address | N/A |
| Telephone | N/A |
| N/A |
